VBI Vaccines: Funding, Investors & Team (Oct 2026)
VBI Vaccines is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines that closely mimic the target virus. VBI is headquartered in Cambridge, MA with research facilities in Ottawa, Canada.
VBI Vaccines has raised $112M across 2 funding rounds on record, the most recent a Post-IPO Debt of $100M announced in Sep 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
VBI Vaccines Company Profile and Key Stats
Latest funding round on record: Sep 2022.
VBI Vaccines Funding Rounds
VBI Vaccines raised $12.0M in an undisclosed round announced in May 2021.
1.3 years later, a Post-IPO Debt of $100M was announced in Sep 2022.
VBI Vaccines Founders and Leadership Team
Contact details for the VBI Vaccines team: 1 of 2 have an email address on file.
Start 14-day free trial →VBI Vaccines Funding Compared to Other Biotechnology Startups
VBI Vaccines' latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like VBI Vaccines in Biotechnology and Cambridge
Companies Similar to VBI Vaccines
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
VBI Vaccines Funding FAQs
What does VBI Vaccines do?
VBI Vaccines is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines that closely mimic the target virus. VBI is headquartered in Cambridge, MA with research facilities in Ottawa, Canada.
How much funding has VBI Vaccines raised?
VBI Vaccines has raised $112M across 2 rounds on record. The most recent is a Post-IPO Debt of $100M announced in Sep 2022.
When did VBI Vaccines last raise funding?
VBI Vaccines' most recent funding round on record is a Post-IPO Debt of $100M, announced in Sep 2022.
Who is the CEO of VBI Vaccines?
Jeff Baxter is listed as CEO at VBI Vaccines.
Where is VBI Vaccines headquartered?
VBI Vaccines is based in Cambridge, Massachusetts, United States.
How many employees does VBI Vaccines have?
VBI Vaccines is in the 101-250 employee band.
How does VBI Vaccines' funding compare to other Biotechnology startups?
VBI Vaccines' latest round of $100M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's VBI Vaccines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for VBI Vaccines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.